US Stock MarketDetailed Quotes

ADAP Adaptimmune Therapeutics

Watchlist
  • 0.570
  • -0.017-2.88%
Trading Feb 27 10:10 ET
145.88MMarket Cap-3.41P/E (TTM)

Adaptimmune Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Adaptimmune Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.300M--
--2024/Q4-- / 8.772M--
Nov 13, 20242024/Q340.901M / 20.489M--
Aug 12, 20242024/Q2128.231M / 44.762M--
May 15, 20242024/Q15.678M / 20.480M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.300M--
--2024/Q4-- / 8.772M--
Nov 13, 20242024/Q340.901M / 20.489M--
Aug 12, 20242024/Q2128.231M / 44.762M--
May 15, 20242024/Q15.678M / 20.480M--

Unlock Free Earnings Estimates

Adaptimmune Therapeutics Earnings Reports

  • Adaptimmune Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13, 2024 16:24 ET

  • Adaptimmune Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12, 2024 07:26 ET

  • Adaptimmune Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 15, 2024 22:23 ET

  • Adaptimmune Therapeutics | 10-K: FY2023 Annual Report

    Mar 6, 2024 07:18 ET

    • Read more

    Trending Stocks

    Market Hot Picks Market Hot Picks
    No. Symbol Price
    NVIDIA
    NVDA
    128.000
    Tesla
    TSLA
    285.185
    Super Micro Computer
    SMCI
    45.990
    4
    Palantir
    PLTR
    88.310
    5
    Applovin
    APP
    314.490
    Log In for the Full List
    Unlock Now